| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000255571.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033926586 |
Resistant |
| ENSG00000255571.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038781549 |
Sensitive |
| ENSG00000255571.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048807601 |
Sensitive |
